Records are supplied by study sponsors and investigators. A registry listing is not an endorsement or a guarantee of safety, availability or eligibility.
WCR feed checked: Nov 12, 2026.
RecruitingNCT07708064
Overweight or Obesity
Not applicable18 years - 75 yearsSpringfield, Oregon, United States This trial will test the effectiveness of a weight loss maintenance intervention designed to help participants respond more adaptively to weight regain. Participants will be randomly assigned to one of two conditions. In one condition, participants w…
RecruitingNCT06792721
Breast Carcinoma · Genetic Predisposition to Cancer · BRCA Mutation · cfMB · Mutation Burden
Observational30 years - 50 yearsCaen, France, France Cancer-free women with a hereditary predisposition to breast and/or ovarian cancer
Active, not recruitingNCT07928544
Retrolaminar Block · Intercostal Nerve Block
Phase 418 years - 80 yearsCairo, Egypt Retrolaminar block (RLB)(a modified form of paravertebral block (PVB) and The ultrasound-guided rhomboid intercostal block (UG-RIB) used to alleviate the postoperative pain in video assisted thoracic surgery (VATS). We hypothesized that RLB may offer…
RecruitingNCT07896109
Diabetes Mellitus, Type 2
Phase 125 years - 69 yearsNeuss, Germany The purpose of this clinical study is to determine if the study medicine NNC9836-0001 is safe and tolerable in healthy participants with overweight or obesity or who have type 2 diabetes (T2D). Participants will either get the study medicine NNC9836-…
CompletedNCT03910660
Prostate Cancer · Neuroendocrine Tumors · Small Cell Carcinoma
Phase 1 / Phase 218 years - Not specifiedSan Francisco, California, United States +11 An open-label, multicenter, Phase 1b/2 study to identify the recommended Phase 2 dose and assess the efficacy and safety of talabostat administered orally, as monotherapy and in combination with pembrolizumab, in participants with mCRPC. Participants…
Not yet recruitingNCT07925697
Myeloid Neoplasms (AML/MDS)
Observational18 years - Not specifiedArgenteuil, France +4 The preDDX registry aims to study germline genetic predispositions to myeloid neoplasms, in particular those associated with pathogenic DDX41 variants and emerging syndromes.
RecruitingNCT07631650
Head and Neck Disorder · Head and Neck Cancer
Phase 218 years - Not specifiedPittsburgh, Pennsylvania, United States Bevonescein (ALM-488) is a novel fluorescein-containing peptide that is intended as a visualization adjunct for the real-time enhanced structural delineation of major nerves during Head and Neck surgery to potentially improve patient outcomes.
Active, not recruitingNCT07036523
Idiopathic Pulmonary Fibrosis
Phase 240 years - Not specifiedBirmingham, Alabama, United States +44 This study is open to adults who are at least 40 years old and have idiopathic pulmonary fibrosis (IPF). People can participate in the study if they have a forced vital capacity (FVC) greater than or equal to 45% of the predicted value and fibrosis o…
SuspendedNCT04975217
Pancreatic Ductal Adenocarcinoma
Early Phase 118 years - Not specifiedHouston, Texas, United States This early phase I trial examines the safety and effects of fecal microbial transplants in treating patients with pancreatic cancer. scheduled for surgery to remove tumors. Fecal microbial transplant contains the normal microbes found in fecal (stool…
Not yet recruitingNCT07524530
Core Binding Factor Alpha Subunits · Hematologic Neoplasms · Leukemia · Lymphoma
Phase 24 years - 70 yearsBethesda, Maryland, United States Background: Some blood cancers can be caused by germline variants (changes) in a person s RUNX1 gene. Germline variants are genetic inherited changes a person is born with. Stem cell transplants are used to treat many diseases including blood cancers…
RecruitingNCT07927283
Metabolic Syndrome
Not applicable18 years - 65 yearsPhoenix, Arizona, United States Fulvic acid is a naturally occurring compound derived from the decomposition of organic matter in soil over long periods. Fulvic acid complexes, such as MLG-50 (MLG-50® Mineral Logic, Kalamazoo, Michigan), offer a highly concentrated, water-soluble f…
Active, not recruitingNCT02979522
Hodgkin Disease
Phase 1 / Phase 25 years - 17 yearsAurora, Colorado, United States +11 The purpose of this study is to assess the safety, tolerability, and anti-tumor activity, as well as confirm the recommended dose of brentuximab vedotin (ADCETRIS) in combination with a multiagent chemotherapy regimen, doxorubicin (Adriamycin), vinbl…
Retrieved from ClinicalTrials.gov: Nov 12, 2026. Overall study status may differ from a particular location’s status.
